In vitro activity of cefoperazone-sulbactam: Singapore experience

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 27, Issue 4, 1996, Pages 734-737

  Kumarasinghe, Gamini ^a   Chow, Carol ^a   Chiu, Cindy ^a   Cheong, Yuet Meng ^b  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b Pfizer   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEFOPERAZONE; CEPHALOSPORIN DERIVATIVE; SULBACTAM;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG COMBINATION; DRUG EFFECT; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HUMAN; SINGAPORE;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; CEFOPERAZONE; CEPHALOSPORIN RESISTANCE; CEPHALOSPORINS; DRUG THERAPY, COMBINATION; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; SINGAPORE; SULBACTAM;

EID: 0030310288     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Barry AL, Jones RN The collaborative antimicrobial susceptibility testing group. Criteria for disc susceptibility tests and quality control guidelines for the cefoperazone-sulbactam combination. J Clin Microbiol 1988; 26 : 13-7.
2. Barry AL, Jones RN. In vitro activities of ampicillin-sulbactam and cefoperazone-sulbactam against oxacillin-susceptible and oxacillin-resistant staphylococci. Antimicrob Agents Chemother 1990; 34 : 1830-2.
3. Eliopoulos GM, Klimm K, Ferraro MJ, et al. In vitro activity of cefoperazone-resistant combinations against cefoperazone resistant clinical bacterial isolates. Eur J Clin Microbiol Infect Dis 1989; 8 : 624-6.
4. Fasola EL, Fasching CE, Peterson LR. Molecular correlation between in vitro and in vivo activity of beta lactam and beta lactamase inhibitor combinations against methicillin-Tesistant Staphylococcus aureus. J Lab Clin Med 1995; 125 : 200-11.
5. Inglis TJJ, Kumarasinghe G, Chow C, et al. Multiple antibiotic resistance in Klebsiella spp and other Entero-bacteriaceae isolated in Singapore. Singapore Med J 1995; 35 : 602-4.
6. Knapp CC, Sierra-Madero J, Washington JA, et al. Comparative in vitro activity of cefoperazone and various combinations of cefoperazone/sulbactam. Diagn Microbiol Infect Dis 1990; 13 : 45-9.
7. Kumarasinghe G, Chow C, Liew HY, et al. Antimicrobial resistance: Patterns and trends in the National University Hospital, Singapore (1989-1991). Malay J Pathol 1992; 14 : 95-103.
8. Kumarasinghe G, Chow C, Koh BL, et al. Antimicrobial resistance problem in a University Hospital. Pathology 1995; 27 : 67-70.
9. McLaughlin JC, Barry AL, Fuchs PC, et al. In vitro activity of five beta-lactam/ beta-lactamase inhibitor combinations against consecutive isolates of the Enterobacteriaceae and Psedomonas aeruginosa. J Antimicrob Agents Chemother 1994; 33 : 223-30.
10. Payne DJ, Cramp R, Winstantly DJ, et al. Comparative activities of clavulanic acid, sulbactam, and tazobactam against clinically important betalactamases. Antimicrob Agents Chemother 1994; 38 : 767-72.
11. Wexler HM, Finegold SM. In vitro activity of cefoperazone plus sulbactam compared with that of other antimicrobial agents against anaerobic bacteria. Antimicrob Agents Chemother 1988; 32 : 403-6.